Results 11 - 15 of 146
Download (Excel compatible)
Thyroid method 8c: In vitro human adipose stromal cell—human umbilical vein endothelial cell (hASC-HUVEC) vasculogenesis/angiogenesis method
TM Status: Closed
Test Method Number: TM2019-19 (EU)
Short Name of TM: VAAN-hadum
Responsible Organisation: EURL ECVAM - European Union
Topic(s): Endocrine disruption
-
Submission
-
Validation
-
Peer-review
-
Recommendation
-
Regulatory acceptance/Standards
Thyroid method 8a: Measurement of proliferation of rat pituitary-derived cell line GH3
TM Status: Closed
Test Method Number: TM2019-17 (EU)
Short Name of TM: T-SCREEN
Responsible Organisation: EURL ECVAM - European Union
Topic(s): Endocrine disruption
-
Submission
-
Validation
-
Peer-review
-
Recommendation
-
Regulatory acceptance/Standards
Thyroid method 6b: CALUX human thyroid hormone receptor beta (TRβ) reporter gene transactivation measuring agonist and antagonist activities
TM Status: Closed
Test Method Number: TM2019-15 (EU)
Short Name of TM: TRβ-CALUX
Responsible Organisation: EURL ECVAM - European Union
Topic(s): Endocrine disruption
-
Submission
-
Validation
-
Peer-review
-
Recommendation
-
Regulatory acceptance/Standards
Thyroid method 6a: Human thyroid hormone receptor alpha (TRα) and Human thyroid hormone receptor beta (TRβ) reporter gene transactivation measuring agonist activities
TM Status: Closed
Test Method Number: TM2019-14 (EU)
Short Name of TM: TRαTRβ-REP
Responsible Organisation: EURL ECVAM - European Union
Topic(s): Endocrine disruption
-
Submission
-
Validation
-
Peer-review
-
Recommendation
-
Regulatory acceptance/Standards
Thyroid method 5a: Inhibition of monocarboxylate transporter 8 (MCT8) based on Sandell-Kolthoff reaction
TM Status: Closed
Test Method Number: TM2019-13 (EU)
Short Name of TM: MCT8-TR
Responsible Organisation: EURL ECVAM - European Union
Topic(s): Endocrine disruption
-
Submission
-
Validation
-
Peer-review
-
Recommendation
-
Regulatory acceptance/Standards